Diabetes Mellitus (type 2) Flashcards
Definition
· Characterised by increased peripheral resistance to insulin action, impaired insulin secretion and increased hepatic glucose output
Aetiology/Risk factors
· Genetic and environmental
· There are a few monogenic causes of diabetes (e.g. MODY, mitochondrial diabetes)
· Obesity increases the risk of T2DM (due to the action of adipocytokines)
· Diabetes can happen secondary to:
o Pancreatic disease (e.g. chronic pancreatitis)
o Endocrine disease (e.g. Cushing’s syndrome, acromegaly, phaeochromocytoma, glucagonoma)
o Drugs (e.g. corticosteroids, atypical antipsychotics, protease inhibitors)
Epidemiology
· UK Prevalence: 5-10%
· Asian, African and Hispanic people are at greater risk
· Incidence has increased over the past 20 yrs
· This is linked to an increasing prevalence of obesity
Presenting symptoms
· May be an incidental finding
· Polyuria
· Polydipsia
· Tiredness
· Patients may present with hyperosmolar hyperglycaemic state (HHS)
· Infections (e.g. infected foot ulcers, candidiasis, balanitis)
· Assess cardiovascular risk factors: hypertension, hyperlipidaemia and smoking
Signs on physical examination
· Calculate BMI
· Waist circumference
· Blood pressure
· Diabetic foot
Signs on physical examination (diabetic foot)
· Diabetic foot (ischaemic and neuropathic signs)
o Dry skin o Reduced subcutaneous tissue o Ulceration o Gangrene o Charcot's arthropathy o Weak foot pulses
Signs on physical examination (skin changes)
· Skin changes (RARE):
o Necrobiosis lipoidica diabeticorum (well-demarcated plaques on shins or arms with shiny atrophic surface and red-brown edges)
o Granuloma annulare (flesh-coloured papules coalescing in rings on the back of hands and fingers)
o Diabetic dermopathy (depressed pigmented scars on shins)
Investigations (diagnosis)
· T2DM is diagnosed if one or more of the following are present:
o Symptoms of diabetes and a random plasma glucose > 11.1 mmol/L
o Fasting plasma glucose > 7 mmol/L
o Two-hour plasma glucose > 11.1 mmol/L after 75 g oral glucose tolerance test
Investigations (monitor)
o HbA1c o U&Es o Lipid profile o eGFR o Urine albumin: creatinine ration (look out for microalbuminuria)
Management plan (glycaemic control)
· Glycaemic control - there is a step-wise approach to the management of T2DM:
o At diagnosis: lifestyle + metformin
o If HbA1c > 7% after 3 months: lifestyle + metformin + sulphonylurea
o If HbA1c > 7% after 3 months: lifestyle + metformin + basal insulin
o If HbA1c > 7% after 3 months and fasting blood glucose > 7 mmol/L: add premeal rapid-acting insulin
o NOTE: sulphonylurea may be given as a monotherapy if patients cannot tolerate metformin
o NOTE: pioglitazone (thiazolidinedione) may also be given alongside metformin and a sulphonylurea
Management plan (screening for complications)
o Retinopathy
o Nephropathy
o Vascular disease
o Diabetic foot
o Cardiovascular risk factors (e.g. blood pressure, cholesterol)
Management plan (other)
· Pregnancy - requires strict glycaemic control and planning of conception
· Hyperosmolar Hyperglycaemic State - management is similar DKA
o Except use 0.45% saline if serum Na+ > 170 mmol/L
Possible complications (hyperosmolar hyperglycaemic state)
o Due to insulin deficiency o Marked dehydration o High Na+ o High glucose o High osmolality o No acidosis
Possible complications (neuropathy)
o Distal symmetrical sensory neuropathy o Painful neuropathy o Carpel tunnel syndrome o Diabetic amyotrophy o Mononeuritis o Autonomic neuropathy o Gastroparesis (abdominal pain, nausea, vomiting) o Impotence o Urinary retention
Possible complications (nephropathy)
o Microabuminuria o Proteinuria o Renal failure o Prone to UTI o Renal papillary necrosis